Neuroscience×In vitro

The Frontier Brief for this collision is still being written. The evidence below already reflects the current model run.

Pre-company space. No named players have staked this collision yet — an emerging pairing where the field, not a firm, is the story so far.

35 researchers publish on both sides of this collision without the fields themselves having met. Every name below is counted from papers in the corpus — not inferred.

• Donald E. IngberInspire
  3/2
• Hans CleversLustgarten Foundation
  2/2
• Maximilian A. BenzInspire
  1/2
• Meritxell HuchMRC Laboratory of Molecular Biology
  2/1
• Olivier HenryInspire
  1/2
• Matthias P. LütolfUniversity Hospital of Basel
  2/1
• Rizwan Hasan KhanJamia Millia Islamia
  1/2
• Lijie Grace ZhangWashington University Medical Center
  1/1
• Syed Mohammad ZakariyaJamia Millia Islamia
  1/1
• Michael C. McAlpineMNGI Digestive Health
  1/1

• Harvard UniversityUS
  218/17
• ETH ZurichCH
  111/7
• University of CambridgeGB
  87/7
• Howard Hughes Medical InstituteUS
  187/3
• Centre National de la Recherche ScientifiqueFR
  82/6
• Chinese Academy of SciencesCN
  60/7

• Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies2019 · 606 citations · DOI ↗
  1
• Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation2019 · 129 citations · DOI ↗
  1
• Microfluidic-enhanced 3D bioprinting of aligned myoblast-laden hydrogels leads to functionally organized myofibers in vitro and in vivo2017 · 331 citations · DOI ↗
  3
• 3D neural tissue models: From spheroids to bioprinting2017 · 273 citations · DOI ↗
  3

Counted from the corpus. Institution counts use best-effort affiliation (every author on a paper is paired with every institution on it), so read them as presence, not headcount.